University of Colorado Denver
School of Medicine
Associate Professor
Office Ph: (303) 724-4221
Lab Ph: (303) 724-4281
Fax: (303) 724-4226
E-mail: michael.schurr@uchsc.edu
Address:
Microbiology, Mail Stop 8333
Building RC-1N, Rm. P18-9113
12800 E. 19th Avenue
P.O. Box 6511
Aurora, CO 80045
Michael J. Schurr
Associate Professor Ph.D., University of North Texas
Current Research
The focus of research efforts in my laboratory is on the pathogenic mechanisms of Pseudomonas aeruginosa, specifically in cystic fibrosis (CF) chronic respiratory infections. The leading cause of morbidity and mortality in CF is due to complications of chronic P. aeruginosa infection. P. aeruginosa is a Gram-negative soil and water microorganism that is capable of causing a plethora of different infections in patients whose innate immune systems have been compromised by either treatment or disease. In CF, many different environmental and host immune factors affect P. aeruginosa such that a majority of the organisms isolated from these patient’s lungs over time exhibit an altered phenotype termed mucoidy. Mucoidy is the direct result of over-producing the exopolysaccharide alginate that allows the organism to hide from the immune system and quench reactive oxygen intermediates. My laboratory is focused on one of the first transcriptional regulators identified to be important for the mucoid phenotype, AlgR, as it appears to be a global regulator of virulence in P. aeruginosa. We have been able to show that AlgR controls at least five different virulence determinants (alginate, pyoverdin, pili function, chemotaxis and HCN production) in P. aeruginosa. We have focused on HCN production, its role in P. aeruginosa pathogenesis and the role of AlgR in its production. We have observed that a majority (86%) of clinical CF P. aeruginosa isolates produced elevated amounts of HCN. In addition, we have discovered that AlgR and AlgZ control this process and these two proteins are likely operating as a two-component regulatory system. This may have significant implications for future therapeutics for P. aeruginosa as well as other bacterial pathogens.
Another interesting dimension is that our data indicates that mucoid P. aeruginosa may be producing HCN in biofilms. There is ample evidence that P. aeruginosa exists as a biofilm in CF patient lungs. However, the virulence of clinical CF P. aeruginosa isolates is greatly reduced. Our data indicates that P. aeruginosa may be actively making HCN in these biofilms and hence in the lungs of CF patients.
We also examine factors governing host-pathogen interactions with both the microbes and the host being examined at different levels using tools spanning areas from genetics to cell biology. The ongoing investigations are in the following areas: (i) stress response in P. aeruginosa; (ii) the relationship between stress response and inflammation and; (iii) animal models of respiratory infection in normal and transgenic mice.
Recent Publications
Click Here For An Updated List Of Dr. Schurr's Publications
L. A. Morici, A. J. Carterson, V. E. Wagner, A. Frisk, J. R. Schurr, K., Höner zu Bentrup, D. J. Hassett, B. H. Iglewski, K. Sauer, and M. J. Schurr. Pseudomonas aeruginosa AlgR Represses the Rhl Quorum-Sensing System in a Biofilm-Specific Manner In Press for J. Bact. 2007.
Molecular Paradigms of Infectious Disease: A Bacterial Perspective. C. A., Nickerson and M. J. Schurr (eds.). Springer publisher, New York, NY. 2006.
Yoon, S. S., Lymar S. V., Schurr, M. J., Hennigan R. F., Hwang, S. H., Coakley R., Boucher R. C., and D. J. Hassett. Killing Mucoid Pseudomonas aeruginosa With Nitric Oxide Via the Pro-Drug, Nitrite: Implications for Therapy of Cystic Fibrosis. Journal of Clinical Investigation. 116:436-446. 2006.
Carterson, A. J., Ott, C. M., Clarke, M. S., Pierson D. L., Vanderburg, C. R., Nickerson, C. A., Buchanan, K. L. and M. J. Schurr. A549 Lung Epithelial Cells Grown As 3-D Aggregates: Alternative Tissue Culture Model for P. aeruginosa Pathogenesis. Infect. Immun. 73:1129-1140. 2005.
Lizewski, S. E., Schurr, J. R., Jackson, D. W., Frisk, A., Carterson, A. J. and M. J. Schurr. Identification of AlgR Regulated Genes in Pseudomonas aeruginosa Using Microarray Analysis. J. Bacteriol. 186:5672-5684. 2004.
Frisk, A., Schurr, J. R., Wang, G., Bertucci, D., Marrero, L., Hwang, S. H., Hassett, D. J. and M. J. Schurr. Transcriptome analysis of Pseudomonas aeruginosa after interaction with human airway epithelial cells. Infect. Immun. 72:5433-5438. 2004.
Carterson, A. J., Morici, L. A., Jackson, D. W., Frisk, A., Lizewski, S. E., Jupiter, R., Simpson, K., Kunz, D. A., Davis, S.H., Schurr, J. R., Hassett, D. J. and M. J. Schurr. The Transcriptional Regulator AlgR Controls Cyanide Production
in Pseudomonas aeruginosa J. Bacteriol. 186:6837-6844. 2004.
Lizewski, S. E., Lundberg, D. S. and M. J. Schurr. The transcriptional regulator AlgR is essential for Pseudomonas aeruginosa pathogenesis. Infect. Immun. 70:6083-6093. 2002.
